Mednet Logo
HomeGynecologic OncologyQuestion

What clinical and pathological factors guide your decision making when considering whether to recommend vaginal cuff brachytherapy following TAH/BSO for a FIGO stage IA or IB endometrial carcinoma?

2 Answers
Mednet Member
Mednet Member
Radiation Oncology · St. Luke’s Cancer Center

The most important risk factors for vaginal wall recurrence for endometrioid adenocarcinomas are grade, depth of invasion and presence of lymphovascular invasion. Now that stage IA includes endometrium only and up to 50% myometrial invasion, it is important to consider the other risk factors. I usua...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Loyola University Chicago Stritch School of Medicine

Overall, I agree with @Dr. First Last's comments. I would add that when deciding on therapy I also use age - with older being at higher risk.

Register or Sign In to see full answer

What clinical and pathological factors guide your decision making when considering whether to recommend vaginal cuff brachytherapy following TAH/BSO for a FIGO stage IA or IB endometrial carcinoma? | Mednet